Gametocyte clearance in children, from western Kenya, with uncomplicated Plasmodium falciparum malaria after artemether–lumefantrine or dihydroartemisinin–piperaquine treatment

Table 2 Plasmodium falciparum gametocyte density during follow up

Days	Artemether–lumefantrine	Dihydroartemisinin–piperaquine	p value
Day 0	1.98 (0.87–5.30)	2.66 (0.82–4.15)	0.388
Day 7	1.23 (0.15–2.45)	0.92 (0.21–2.85)	0.439
Day 14	0.50 (0.12–1.26)	0.65 (0.34–2.28)	0.457
Day 21	0.34 (0.12–0.76)	0.72 (0.20–1.94)	0.529
Day 28	0.43 (0.32–1.18)	0.53 (0.38–1.84)	0.621
Day 42	0.42 (0.22–1.25)	0.37 (0.16–0.42)	0.355

Data included: gametocyte positive individuals. Median density on day 7, 14, 28 and 42 is not necessarily assessed over the same individuals used to determine gametocyte density at enrolment
*p-value represents difference between groups. Difference in gametocyte density was tested using the Wilcoxon rank-sum test. Median and IQR

ISSN: 1475-2875